Preparation for FDA Advisory Panel and Other FDA Meetings

Slides:



Advertisements
Similar presentations
Organizational Succession Planning Board Discussion Framework.
Advertisements

Fiscal Law Proposal Mary Margaret Evans Director DRAFT.
 Work with the club president.  Work with club committees.  Assist with the Official Visit.  Work with the assistant governor.  Maintain and create.
Achieving Success as Vice President Public Relations Achieving Success as Vice President Public Relations Club Leadership Training Session.
The Practice of Strategy The Strategist. Exploring Corporate Strategy 8e, © Pearson Education 2008 BLB pjc: Core Text Exploring Corporate Strategy.
1 The CMO – One Size Fits All? Jake Julia, Ph.D.Brenda Sprite Northwestern UniversityNavigator Management Partners Session Presented at the Inaugural Global.
FDA Advisory Committees: A Unique Element of our Decision-Making Process Murray M. Lumpkin, M.D. Acting Deputy Commissioner International and Special Programs.
#CPACONGRESS E5: The changing face of the public sector CFO: From provider to strategist Paul Wood, Chief Finance Officer, Department of Foreign Affairs.
Institute for Sustainable Enterprise at the Silberman College of Business Fairleigh Dickinson University ISE Advisory Group Session March 30, 2006.
SPECIAL DIABETES PROGRAM FOR INDIANS Competitive Grant Program: Year 2 Meeting 3 SDPI Diabetes Prevention Program.
1 Advisory Committee Member Training Louis R. Cantilena, Jr., M.D., Ph.D. Former Chair, Nonprescription Drug Advisory Committee Professor of Medicine and.
FDA Advisory Committee Training An Industry Representative Perspective Alison Lawton Sr. VP Regulatory Affairs Genzyme Corporation.
 Speaker of the House – the presiding officer of the House of Rep., selected from the membership.  Floor Leader – A spokesperson for a party in Congress;
Industry Perspective on Challenges for Product Developers - Drugs Christine Allison, M.S., RAC Associate Regulatory Consultant, Global Regulatory Affairs.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA ACPS Subcommittee on Manufacturing Science: Identification and Prioritization.
How can school districts support the development of healthy school communities? Facilitated by: Rhonda Patton, Alberta Health Services Dr. Steve Manske,
Alaska Staff Development Network – Follow-Up Webinar Emerging Trends and issues in Teacher Evaluation: Implications for Alaska April 17, :45 – 5:15.
Strategies for Preparing for Meetings with FDA Susan M. Mondabaugh, Ph.D. Vice President, Regulatory Affairs Hurley Consulting Associates Ltd. Chatham,
©SHRM 2010 State Leadership Conference – An Overview Phyllis Shurn-Hannah, SHRM NE Field Services Director.
After The Inspection When and How to Meet With FDA Presented by: Michael Santalucia Vice President Global Regulatory Affairs – Vision Care Medical Device.
Creating Meaningful CEO Performance Evaluations (Session #T 109) Tuesday, August 11, :30 a.m. – 12:30 p.m. Shawn Boynes, CAE Executive Director,
Public Reporting: Bring Your Lunch and Make Connections Introduction to the AHRQ QI Learning Institute AHRQ Annual Meeting September 9, 2008.
Internal Subject Review Training Tuesday 9 th November 2010 Slaveya Angelska, Associate Trainer Sareta Puri, Development Advisor.
District Training.  Jim Miller  Margaret Brunner
Industry-Friendly Resumés Tips and Pitfalls Pejman Azarmina, MD MSc Sr. Director & Team Leader Pfizer Inc.
WORKING DRAFT Last Modified 10/24/ :10 PM Romance Standard Time Printed Let’s talk about……… Challenges for a New CLO or Learning Leader. Sharing.
HIVQUAL Group Learning Guide – New York State DOH AIDS Institute 1 Facilitation of Quality Program Learning Objectives  To understand the primary responsibilities.
Welcome to IPEC-Americas Strategic Planning: Session 4 Facilitator: Chris Moreton, Ph.D FinnBrit Consulting, Waltham, MA IPEC-Americas Planning Meeting,
Developing a Public Involvement Plan Why Develop a PI Plan? PI Plan Format Public Involvement Training Class – Presented by the Office of Environmental.
Team Work. Why we need team work Steps in Team Work 10 steps.
1 Drug Safety Oversight Board: Recent Activities FDA Science Board Advisory Committee Meeting March 31 st, 2006 Douglas C. Throckmorton, MD Deputy Director.
Do’s and Don’t's of Accreditation Visits Barbara Ford San Francisco State University.
Preparation for FDA Advisory Committee Meetings Robert M. Kirsch, RAC Vice President, Regulatory Affairs TolerRx Inc. Cambridge, MA.
Association of Washington Public Hospital Districts How to Chair a Great Meeting: 10 Things the Chair Must Do to be Successful WSHA Web Conference February.
FDA’s Advisory Committee for Pharmaceutical Science The Subcommittee on Process Analytical Technologies (PAT): Closing Remarks Ajaz S. Hussain, Ph.D. Deputy.
Resuscitation Team Concept. Role of the Team Leader The role of the team leader is multifaceted. The team leader Oranizes the group Moniters individual.
1 Audit of the Columbia Suicidality Classification Project September 13, 2004 Meeting of Psychopharmacological Drugs Advisory Committee and Pediatric Advisory.
EXCEL SPREADSHEET VALIDATION FOR FDA 21 CFR PART 11.
Developing a Public Involvement Plan Why Develop a PI Plan? PI Plan Format Public Involvement Training Class – Presented by the Office of Environmental.
MAKING MEETINGS MATTER Carolyn Russell Karissa Sovdi.
Version: 27 May 2007 New Models for Collaboration: Patients as Drivers and Partners in Neurological Research Integrating Patient Input Within the Drug.
Market Research for Universities
BLM Decision Making Process
Developing a Public Involvement Plan
Nicholson Facilitation & Associates, LLC
The Practice of Strategy
Indiana’s Trajectory toward Supporting Families
Your Internal Audit Team
Governance and Collaboration By-Laws
Desired Discussion/Outcome
New Initiative Netball Practice Night Coach Recruitment Challenges
QUALITY IMPROVEMENT PLAN: Culture of Quality Improvement
Janet Reese and Courtney Davis, Ph.D.
Module 2: Orientation to the Role of an Advisory Coalition
Organizational Succession Planning
Succession Planning & Career Path
Learning Forward Annual Conference Session F28
Your Internal Audit Team
IT Governance Planning Overview
Strategy in Action 15: The Practice of Strategy
Your Internal Audit Team
Action Plans Your teaching – individual
Broadening Horizons Seminar 3.1.
Every meeting has three parts: Ramp-Up, Meeting, Follow-Up.
Lessons Learned from the Mistakes of Others
Teaming Class 2 Notes – Section 1
From SPIL to Skill: Maximizing Youth Engagement in SILCs
Setting Directions for ICON Readiness
Strategic Management and
Strategic Management and
Presentation transcript:

Preparation for FDA Advisory Panel and Other FDA Meetings Margaret E. Hurley, M.D. President and CEO Hurley Consulting Associates Ltd. Chatham, NJ Hurley--Preconf1-8.22@1pm FDA

Session Objectives FDA and Sponsor and Perspective on How to Prepare for Meetings: Elements for Success Best Practices Pitfalls to Avoid

What Session Will Cover Regulations and Requirements Basics of Advisory Committees and Other Meetings: Purpose Membership Function Step-by-Step “How To”

Role of Regulatory Affairs Leader Planner Strategist Tracker Facilitator Team Member Coach One of the Keys to Successful Meetings

Despite This, Not All Meetings Result in the Sponsor’s Desired Outcome Key Success Factors Early Planning Establishing Strategy Preparation Tracking Despite This, Not All Meetings Result in the Sponsor’s Desired Outcome

Program Preparation Strategies for FDA Meetings Break FDA Perspective – Kim Colangelo Sponsor Perspective – Susan Mondabaugh, Ph.D. Break Preparing for Advisory Committee Meetings FDA, CDER’s Advisors & Consultants Staff (ACS) Perspective – Igor Cerny, Pharm.D. Sponsor Perspective – Robert Kirsch, Ph.D. Questions